Researcher
Jeroen Dekervel
- Disciplines:Analysis of next-generation sequence data, Single-cell data analysis, Cancer diagnosis, Cancer therapy
Affiliations
- Digestive Oncology (Division)
Member
From1 Aug 2022 → Today - Clinical Digestive Oncology (Division)
Member
From1 Oct 2018 → Today - Hepatology (Division)
Member
From1 Oct 2012 → 2 Oct 2016
Projects
1 - 4 of 4
- Validation, refinement and spatial orientation of CD45RA effector-memory CD8 T-cells and PDL1- expressing CXCL10+ macrophages as predictive markers for response to immune checkpoint inhibition in advanced hepatocellular carcinoma.From1 Oct 2023 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- [18F]AlF-NOTA-octreotide PET imaging of the somatostatin receptor in neuroendocrine tumors: comparison with [68Ga]Ga-DOTATATE and evaluation of routine clinical use.From3 Oct 2022 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Personalized multimodal treatment for resectable esophageal cancer by detecting minimal residual disease (MRD) using circulating tumor DNA (ctDNA):From11 Jan 2022 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- The search for biomarkers in systemic treatment of advanced hepatocellular carcinoma.From1 Oct 2019 → TodayFunding: FWO Strategic Basic Research Grant
Publications
1 - 10 of 45
- The ongoing search for biomarkers of response to systemic therapy in advanced hepatocellular carcinoma.(2023)
Authors: Sarah Cappuyns, Jeroen Dekervel, Eric Van Cutsem, Chris Verslype, Diether Lambrechts
- 18F-Labeled Somatostatin Analogs as PET Tracers for the Somatostatin Receptor: Ready for Clinical Use(2023)
Authors: Hannes Leupe, Stephen Ahenkorah, Jeroen Dekervel, Eric Van Cutsem, Chris Verslype, Frederik Cleeren, Christophe Deroose
Pages: 835 - 841 - Prospective comparison of [F-18]AlF-NOTA-octreotide PET/MRI to [Ga-68]Ga-DOTATATE PET/CT in neuroendocrine tumor patients(2023)
Authors: Frederik Cleeren, Jeroen Dekervel, Michel Koole, Guy Bormans, Paul Clement, Kristiaan Nackaerts, Koenraad Van Laere, Christophe Deroose
- ANCHOR CRC: Results From a Single-Arm , Phase II Study of Encorafenib Plus Binimetinib and Cetuximab in Previously Untreated BRAF(V600E)-Mutant Metastatic Colorectal Cancer(2023)
Authors: Eric Van Cutsem, Jeroen Dekervel
Pages: 2628 - + - A randomized controlled trial of hand/foot-cooling by hilotherapy to prevent oxaliplatin-related peripheral neuropathy in patients with malignancies of the digestive system(2023)
Authors: Annouschka Laenen, Hans Wildiers, Chris Verslype, Jeroen Dekervel, Eric Van Cutsem
- 18F-AlF-NOTA-Octreotide Outperforms 68Ga-DOTATATE/ NOC PET in Neuroendocrine Tumor Patients: Results from a Prospective, Multicenter Study(2023)
Authors: Elin Pauwels, Frederik Cleeren, Michel Koole, Jeroen Dekervel, Annouschka Laenen, Paul Clement, Eric Van Cutsem, Chris Verslype, Guy Bormans, Christophe Deroose
Pages: 632 - 638 - Development of a Patient Decision Aid for Rectal Cancer Patients with Clinical Complete Response after Neo-Adjuvant Treatment(2023)
Authors: Lien Smets, Eva Oldenburger, Chantal Van Audenhove, Jeroen Dekervel, Albert Wolthuis, Karin Haustermans
- Unraveling the Synergy between Atezolizumab and Bevacizumab for the Treatment of Hepatocellular Carcinoma(2023)
Authors: Lisa Kinget, Sarah Cappuyns, Chris Verslype, Benoit Beuselinck, Jeroen Dekervel
- Pleural decortication and hyperthermic intrathoracic chemotherapy for pseudomyxoma(2022)
Authors: Jan Van Slambrouck, Albert Wolthuis, Jeroen Dekervel, Gert De Hertogh, Dirk Van Raemdonck, Philippe Nafteux, Laurens Ceulemans
Pages: 1153 - 1157 - Nonoperative versus operative approach according to the response to neoadjuvant chemoradiotherapy for rectal cancer: A prospective cohort study(2022)
Authors: Lien Smets, Albert Wolthuis, Jeroen Dekervel, Christophe Deroose, Karin Haustermans
Pages: 113 - 120